CC-11050 Trial in Nepalese Patients With Erythema Nodosum Leprosum
NCT03807362
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
50
Enrollment
OTHER
Sponsor class
Conditions
Erythema Nodosum Leprosum
Leprosy
Interventions
DRUG:
CC-11050
Sponsor
The Leprosy Mission Nepal